Invention Grant
US08809332B2 Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone
有权
用佐匹克隆或替佐氟隆的苯磺酸盐剂型治疗焦虑症的方法
- Patent Title: Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone
- Patent Title (中): 用佐匹克隆或替佐氟隆的苯磺酸盐剂型治疗焦虑症的方法
-
Application No.: US13927439Application Date: 2013-06-26
-
Publication No.: US08809332B2Publication Date: 2014-08-19
- Inventor: Richard Hsia , H. Scott Wilkinson , Tushar Misra , Kostas Saranteas , Patrick Mousaw
- Applicant: Sunovion Pharmaceuticals Inc.
- Applicant Address: US MA Marlborough
- Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee Address: US MA Marlborough
- Agency: Helsin Rothenberg Farley & Mesiti P.C.
- Main IPC: A61K31/444
- IPC: A61K31/444 ; A61K31/495 ; A61K31/4985 ; C07D213/61 ; C07D295/182 ; C07D471/04
Abstract:
Besylate salts of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are provided.
Public/Granted literature
Information query
IPC分类:
